The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
Open accessAbstract
In light of a global rise in obesity and type 2 diabetes, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) represent an increasingly important underlying etiology of hepatocellular carcinoma (HCC). HCCs arising from lipotoxicity-mediated chronic inflammation due to excessive accumulation of neutral lipids in the liver are characterized by several unique features: In contrast to viral-driven HCC, up to 50% of NAFLD-HCC occurs in patients without cirrhosis, and annual HCC incidence is comparatively low, complicating current surveillance strategies. On average, patients are older and diagnosis occurs more frequently at an advanced stage. Locoregional treatments are probably equally effective regardless of HCC etiology. For systemic therapy the picture is less clear. Tyrosine kinase inhibitors are probably equally effective, while there have been first signals that immune checkpoint inhibitors may be less effective in NAFLD-HCC than in viral HCC. To date, treatment recommendations for HCC by international guidelines do not take the underlying etiology into consideration. This review article summarizes the currently available evidence for the efficacy and safety of the various treatment modalities for HCC. There are insufficient data to draw any conclusion and to modify the current management of HCC patients with regard to etiology. However, in light of the growing relevance of NAFLD-HCC, future clinical trials should assess whether HCC etiology - and NAFLD/NASH in particular - influence the safety and efficacy of a given treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Self-citationEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Zhu, A. X., Finn, R. S., Edeline, J., Cattan, S., Ogasawara, S., Palmer, D., Verslype, C., Zagonel, V., Fartoux, L., Vogel, A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30351-6 · Cited by 2,479
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-642_1 · Cited by 2,081
Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,980
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Finn, R. S., Ryoo, B.-Y., Merle, P., Kudo, M., Bouattour, M., Lim, H. Y., Breder, V., Edeline, J., Chao, Y., Ogasawara, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01307 · Cited by 1,789
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Self-citationSenescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Park, J., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P., Kudo, M., Johnson, P., Wagner, S., Orsini, L. S., et al. (2015) · Liver International · doi:10.1111/liv.12818 · Cited by 1,245
Lipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189
Bruix, J., Takayama, T., Mazzaferro, V., Chau, G.-Y., Yang, J., Kudo, M., Cai, J., Poon, R. T., Han, K.-H., Tak, W. Y., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00198-9 · Cited by 1,120
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Sia, D., Jiao, Y., Martinez-Quetglas, I., Kuchuk, O., Villacorta-Martin, C., Castro de Moura, M., Putra, J., Camprecios, G., Bassaganyas, L., Akers, N., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.007 · Cited by 976
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
Recurrence of Hepatocellular Cancer After Resection: Patterns, Treatments, and Prognosis
Tabrizian, P., Jibara, G., Shrager, B., Schwartz, M., & Roayaie, S. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000710 · Cited by 903
Takayama, T., Sekine, T., Makuuchi, M., Yamasaki, S., Kosuge, T., Yamamoto, J., Shimada, K., Sakamoto, M., Hirohashi, S., Ohashi, Y., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02654-4 · Cited by 847
Bruix, J., Raoul, J.-L., Sherman, M., Mazzaferro, V., Bolondi, L., Craxi, A., Galle, P. R., Santoro, A., Beaugrand, M., Sangiovanni, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.014 · Cited by 822
Self-citationRisk of hepatocellular cancer in patients with non-alcoholic fatty liver disease
Kanwal, F., Kramer, J. R., Mapakshi, S., Natarajan, Y., Chayanupatkul, M., Richardson, P. A., Li, L., Desiderio, R., Thrift, A. P., Asch, S. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.024 · Cited by 795
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766
Wolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678
Yau, T., Park, J. W., Finn, R. S., Cheng, A.-L., Mathurin, P., Edeline, J., Kudo, M., Han, K.-H., Harding, J. J., Merle, P., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz394.029 · Cited by 647
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 611
Piscaglia, F., Svegliati‐Baroni, G., Barchetti, A., Pecorelli, A., Marinelli, S., Tiribelli, C., Bellentani, S., & on behalf of the HCC‐NAFLD Italian Study Group (2016) · Hepatology · doi:10.1002/hep.28368 · Cited by 604
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
Shalapour, S., Lin, X.-J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., Vrbanac, A. F., Li, W., Perkins, A., Matsutani, T., et al. (2017) · Nature · doi:10.1038/nature24302 · Cited by 589
Bruix, J., Cheng, A.-L., Meinhardt, G., Nakajima, K., De Sanctis, Y., & Llovet, J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.026 · Cited by 562
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
Lee, J. H., Lee, J.-H., Lim, Y.-S., Yeon, J. E., Song, T.-J., Yu, S. J., Gwak, G.-Y., Kim, K. M., Kim, Y. J., Lee, J. W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.055 · Cited by 503
Behary, J., Amorim, N., Jiang, X.-T., Raposo, A., Gong, L., McGovern, E., Ibrahim, R., Chu, F., Stephens, C., Jebeili, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20422-7 · Cited by 470
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 452
N'Kontchou, G., Mahamoudi, A., Aout, M., Ganne-Carrié, N., Grando, V., Coderc, E., Vicaut, E., Trinchet, J. C., Sellier, N., Beaugrand, M., et al. (2009) · Hepatology · doi:10.1002/hep.23181 · Cited by 450
Resection of hepatocellular cancer ≤2 cm: Results from two Western centers
Roayaie, S., Obeidat, K., Sposito, C., Mariani, L., Bhoori, S., Pellegrinelli, A., Labow, D., Llovet, J. M., Schwartz, M., & Mazzaferro, V. (2013) · Hepatology · doi:10.1002/hep.25832 · Cited by 437
Cortellini, A., Bersanelli, M., Buti, S., Cannita, K., Santini, D., Perrone, F., Giusti, R., Tiseo, M., Michiara, M., Di Marino, P., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0527-y · Cited by 413
Chen, H.-P., Shieh, J.-J., Chang, C.-C., Chen, T.-T., Lin, J.-T., Wu, M.-S., Lin, J.-H., & Wu, C.-Y. (2013) · Gut · doi:10.1136/gutjnl-2011-301708 · Cited by 392
Loomba, R., Lim, J. K., Patton, H., & El-Serag, H. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.053 · Cited by 357
Kichenadasse, G., Miners, J. O., Mangoni, A. A., Rowland, A., Hopkins, A. M., & Sorich, M. J. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.5241 · Cited by 339
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Lim, H. Y., Kudo, M., Breder, V. V., Merle, P., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.3_suppl.267 · Cited by 319
Self-citationHaldar, D., Kern, B., Hodson, J., Armstrong, M. J., Adam, R., Berlakovich, G., Fritz, J., Feurstein, B., Popp, W., Karam, V., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.011 · Cited by 313
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Simon, T. G., Duberg, A.-S., Aleman, S., Chung, R. T., Chan, A. T., & Ludvigsson, J. F. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912035 · Cited by 304
Cho, Y. K., Kim, J. K., Kim, W. T., & Chung, J. W. (2010) · Hepatology · doi:10.1002/hep.23466 · Cited by 276
Facciorusso, A., Di Maso, M., & Muscatiello, N. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1127434 · Cited by 267
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
Shimada, S., Mogushi, K., Akiyama, Y., Furuyama, T., Watanabe, S., Ogura, T., Ogawa, K., Ono, H., Mitsunori, Y., Ban, D., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.058 · Cited by 257
Haber, P. K., Puigvehí, M., Castet, F., Lourdusamy, V., Montal, R., Tabrizian, P., Buckstein, M., Kim, E., Villanueva, A., Schwartz, M., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.008 · Cited by 248
Guiu, B., Petit, J. M., Bonnetain, F., Ladoire, S., Guiu, S., Cercueil, J.-P., Krausé, D., Hillon, P., Borg, C., Chauffert, B., et al. (2010) · Gut · doi:10.1136/gut.2009.188946 · Cited by 245
Gupta, A., Das, A., Majumder, K., Arora, N., Mayo, H. G., Singh, P. P., Beg, M. S., & Singh, S. (2018) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000388 · Cited by 243
Zhang, Z.-J., Zheng, Z.-J., Shi, R., Su, Q., Jiang, Q., & Kip, K. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1267 · Cited by 241
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes
Cholankeril, G., Wong, R. J., Hu, M., Perumpail, R. B., Yoo, E. R., Puri, P., Younossi, Z. M., Harrison, S. A., & Ahmed, A. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4684-x · Cited by 234
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
Pinter, M., Scheiner, B., & Peck-Radosavljevic, M. (2021) · Gut · doi:10.1136/gutjnl-2020-321702 · Cited by 233
Liver Transplantation for Nonalcoholic Steatohepatitis: The New Epidemic
Agopian, V. G., Kaldas, F. M., Hong, J. C., Whittaker, M., Holt, C., Rana, A., Zarrinpar, A., Petrowsky, H., Farmer, D., Yersiz, H., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31826b4b7e · Cited by 228
Reddy, S. K., Steel, J. L., Chen, H.-W., DeMateo, D. J., Cardinal, J., Behari, J., Humar, A., Marsh, W. J., Geller, D. A., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25536 · Cited by 224
VanWagner, L. B., Bhave, M., Te, H. S., Feinglass, J., Alvarez, L., & Rinella, M. E. (2012) · Hepatology · doi:10.1002/hep.25855 · Cited by 220
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
Marin, J. J. G., Macias, R. I. R., Monte, M. J., Romero, M. R., Asensio, M., Sanchez-Martin, A., Cives-Losada, C., Temprano, A. G., Espinosa-Escudero, R., Reviejo, M., et al. (2020) · Cancers · doi:10.3390/cancers12061663 · Cited by 199
Simon, T. G., Henson, J., Osganian, S., Masia, R., Chan, A. T., Chung, R. T., & Corey, K. E. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.061 · Cited by 180
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Sohn, W., Lee, H. W., Lee, S., Lim, J. H., Lee, M. W., Park, C. H., & Yoon, S. K. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0176 · Cited by 177
Mohamad, B., Shah, V., Onyshchenko, M., Elshamy, M., Aucejo, F., Lopez, R., Hanouneh, I. A., Alhaddad, R., & Alkhouri, N. (2016) · Hepatology International · doi:10.1007/s12072-015-9679-0 · Cited by 166
Feng, M., Suresh, K., Schipper, M. J., Bazzi, L., Ben-Josef, E., Matuszak, M. M., Parikh, N. D., Welling, T. H., Normolle, D., Ten Haken, R. K., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2303 · Cited by 165
Citterio, D., Facciorusso, A., Sposito, C., Rota, R., Bhoori, S., & Mazzaferro, V. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.1121 · Cited by 164
Mediterranean diet and hepatocellular carcinoma
Turati, F., Trichopoulos, D., Polesel, J., Bravi, F., Rossi, M., Talamini, R., Franceschi, S., Montella, M., Trichopoulou, A. D., Vecchia, C. L., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.034 · Cited by 155
Ferrer, J., Forner, A., Liccioni, A., Miquel, R., Molina, V., Navasa, M., Fondevila, C., García‐Valdecasas, J. C., Bruix, J., & Fuster, J. (2015) · Hepatology · doi:10.1002/hep.28339 · Cited by 145
Park, H. J., Jang, H. Y., Kim, S. Y., Lee, S. J., Won, H. J., Byun, J. H., Choi, S. H., Lee, S. S., An, J., & Lim, Y. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.001 · Cited by 137
Pais, R., Fartoux, L., Goumard, C., Scatton, O., Wendum, D., Rosmorduc, O., & Ratziu, V. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14261 · Cited by 129
Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome
Cauchy, F., Zalinski, S., Dokmak, S., Fuks, D., Farges, O., Castéra, L., Paradis, V., & Belghiti, J. (2012) · British journal of surgery · doi:10.1002/bjs.8963 · Cited by 129
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma
Heinrich, B., Gertz, E. M., Schäffer, A. A., Craig, A. J., Ruf, B., Subramanyam, V., McVey, J. C., Diggs, L. P., Heinrich, S., Rosato, U., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-325288 · Cited by 125
The immune contexture of hepatocellular carcinoma predicts clinical outcome
Foerster, F., Hess, M., Gerhold‐Ay, A., Marquardt, J. U., Becker, D., Galle, P. R., Schuppan, D., Binder, H., & Bockamp, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21937-2 · Cited by 122
Self-citationTreatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Weinmann, A., Alt, Y., Koch, S., Nelles, C., Düber, C., Lang, H., Otto, G., Zimmermann, T., Marquardt, J. U., Galle, P. R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1197-x · Cited by 115
Self-citationViganò, L., Conci, S., Cescon, M., Fava, C., Capelli, P., D’Errico, A., Torzilli, G., Tommaso, L. D., Giuliante, F., Vecchio, F. M., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.024 · Cited by 113
Loebig, M., Klement, J., Schmoller, A., Betz, S., Heuck, N., Schweiger, U., Peters, A., Schultes, B., & Oltmanns, K. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012610 · Cited by 110
Chen, T., Lin, C., Huang, P., & Wen, C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06664.x · Cited by 107
Simkens, L. H. J., Koopman, M., Mol, L., Veldhuis, G. J., Huinink, D. T. B., Muller, E. W., Derleyn, V. A., Teerenstra, S., & Punt, C. J. A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.038 · Cited by 101
Baumeister, S. E., Schlesinger, S., Aleksandrova, K., Jochem, C., Jenab, M., Gunter, M. J., Overvad, K., Tjønneland, A. M., Boutron‐Ruault, M., Carbonnel, F., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.014 · Cited by 101
Gardini, A. C., Faloppi, L., Matteis, S. D., Foschi, F. G., Silvestris, N., Tovoli, F., Palmieri, V. O., Marisi, G., Brunetti, O., Gentilucci, U. V., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.003 · Cited by 92
Jayakumar, S., & Loomba, R. S. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 92
Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Wakai, T., Shirai, Y., Sakata, J., Korita, P. V., Ajioka, Y., & Hatakeyama, K. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1540-8 · Cited by 91
Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma
Samoylova, M. L., Mehta, N. J., Roberts, J. P., & Yao, F. Y. (2018) · Liver Transplantation · doi:10.1002/lt.25202 · Cited by 79
Kwak, M., Mehaffey, J. H., Hawkins, R. B., Hsu, A., Schirmer, B. D., & Hallowell, P. T. (2019) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2019.09.006 · Cited by 79
Majumdar, A., Roccarina, D., Thorburn, D., Davidson, B. R., Tsochatzis, E. A., & Gurusamy, K. S. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30726-2 · Cited by 73
The role of the innate immune system in the development and treatment of hepatocellular carcinoma
Roderburg, C., Wree, A., Demir, M., Schmelzle, M., & Tacke, F. (2020) · Hepatic Oncology · doi:10.2217/hep-2019-0007 · Cited by 72
Geh, D., Manas, D., & Reeves, H. L. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.08.08 · Cited by 69
Radiotherapy for HCC: Ready for prime time?
Bang, A., & Dawson, L. A. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.05.004 · Cited by 67
Memel, Z. N., Arvind, A., Moninuola, O., Philpotts, L. L., Chung, R. T., Corey, K. E., & Simon, T. G. (2020) · Hepatology Communications · doi:10.1002/hep4.1640 · Cited by 60
Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
Koh, Y. X., Tan, H. J., Liew, Y. X., Syn, N. L. X., Teo, J. Y., Lee, S. Y., Goh, B. K. P., Goh, G. B., & Chan, C. Y. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.07.012 · Cited by 59
Ninomiya, K., Oze, I., Kato, Y., Kubo, T., Ichihara, E., Rai, K., Ohashi, K., Kozuki, T., Tabata, M., Maeda, Y., et al. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1695062 · Cited by 54
Wong, C., Njei, B., Nguyen, M., Nguyen, A., & Lim, J. K. (2017) · Alimentary Pharmacology and Therapeutics · doi:10.1111/apt.14342 · Cited by 51
Yang, T., Hu, L., Li, Z., Liu, K., Wu, H., Xing, H., Lau, W. Y., Pawlik, T. M., Zeng, Y., Zhou, Y.-H., et al. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-04071-2 · Cited by 47
Wong, R. J., Chou, C., Bonham, C. A., Concepcion, W., Esquivel, C. O., & Ahmed, A. (2014) · Clinical Transplantation · doi:10.1111/ctr.12364 · Cited by 46
Aparicio, T., Ducreux, M. P., Faroux, R., Barbier, E., Manfrédi, S., Lecomte, T., Etienne, P.-L., Bedenne, L., Bennouna, J., Phelip, J., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.03.031 · Cited by 46
Landre, T., Guetz, G. D., Chouahnia, K., Fossey-Diaz, V., & Culine, S. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00788-5 · Cited by 43
Kawaguchi, T., Tokushige, K., Hyogo, H., Aikata, H., Nakajima, T., Ono, M., Kawanaka, M., Sawada, K., Imajo, K., Honda, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28650-0 · Cited by 42
Mechanisms of nonalcoholic fatty liver disease and implications for surgery
Kaufmann, B. K., Reca, A., Wang, B., Friess, H., Feldstein, A. E., & Hartmann, D. (2020) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-020-01965-1 · Cited by 41
Khaddour, K., Gomez‐Perez, S. L., Jain, N., Patel, J. D., & Boumber, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.576314 · Cited by 36
Schotten, C., Bechmann, L. P., Manka, P. P., Theysohn, J. M., Dechêne, A., Fouly, A. E., Barbato, F., Neumann, U., Radünz, S., Sydor, S., et al. (2019) · Liver Cancer · doi:10.1159/000501484 · Cited by 33
Karin, M. (2018) · Precision Clinical Medicine · doi:10.1093/pcmedi/pby005 · Cited by 30
Chung, A. S., Mettlen, M., Ganguly, D., Lu, T., Wang, T., Brekken, R. A., Hsiehchen, D., & Zhu, H. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0200 · Cited by 29
Molinari, M., Kaltenmeier, C., Bou‐Samra, P., Liu, H., Wessel, C. B., Klem, M. L., Dharmayan, S., Emmanuel, B., Harakeh, H. A., Tohme, S. T., et al. (2021) · Annals of Surgery Open · doi:10.1097/as9.0000000000000065 · Cited by 28
Wu, S. E., Charles, H. W., Park, J. S., et al. (2016) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2016.06.002 · Cited by 24
Young, S. J., Sanghvi, T. S., Rubin, N., Hall, D., Roller, L., Charaf, Y., & Golzarian, J. (2019) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-019-02363-x · Cited by 24
Kolamunnage‐Dona, R., Berhane, S., Potts, H., Williams, E. H., Tanner, J., Janowitz, T., Hoare, M., & Johnson, P. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.015 · Cited by 24
The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
Kogiso, T., & Tokushige, K. (2021) · Cancers · doi:10.3390/cancers13030516 · Cited by 21
Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients
Artaç, M., Korkmaz, L., Çoşkun, H. Ş., Dane, F., Karabulut, B., Karaağaç, M., Çabuk, D., Karabulut, S., Aykan, N. F., Doruk, H., et al. (2018) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-0047-2 · Cited by 19
Billeter, A. T., Müller, P. C., Albrecht, T., Roessler, S. K., Löffler, M., Murtha-Lemekhova, A., Mehrabi, A., Müller-Stich, B. P., & Hoffmann, K. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-020-04628-0 · Cited by 18
Yacoub, J. H., Hsu, C. C.-S., Fishbein, T., Mauro, D. M., Moon, A. M., He, A. R., Bashir, M. R., & Burke, L. M. B. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03069-w · Cited by 18
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
Campani, C., Bensi, C., Milani, S., Galli, A., & Tarocchi, M. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s252506 · Cited by 12
Cited by
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
“[159] Although comorbidities associated with NASH may prevent potentially curative therapies in a higher proportion of patients compared with viral-related HCC, outcomes are similar among those who undergo resection.”
Neutrophil extracellular traps in homeostasis and disease
Wang, H., Kim, S. J., Lei, Y., Wang, S., Wang, H., Huang, H., Zhang, H., & Tsung, A. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01933-x · Cited by 537
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Llovet, J. M., Willoughby, C. E., Singal, A. G., Greten, T. F., Heikenwälder, M., El-Serag, H. B., Finn, R. S., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00754-7 · Cited by 354
Song, Q., Zhang, X., Liu, W., Wei, H., Liang, W., Zhou, Y., Ding, Y., Ji, F., Ho-Kwan Cheung, A., Wong, N., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.005 · Cited by 293
Rusu, I., Pirlog, R., Chiroi, P., Nutu, A., Puia, V. R., Fetti, A. C., Rusu, D. R., Berindan-Neagoe, I., & Al Hajjar, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012370 · Cited by 27
Metadata
- Authors
- Foerster, F., Gairing, S. J., Müller, L., & Galle, P. R.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 76
- Issue
- 2
- Pages
- 446-457
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3199671553
- Cited by
- 280
- References
- 118
- FWCI
- 22.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.